肥胖终末期肾病患者移植候选资格的协作路径
本研究报道单中心183例终末期肾病(ESRD)患者经移植团队转诊至减重团队,其中36例接受代谢减重手术(MBS;20例Roux-en-Y胃旁路术、16例袖状胃切除术),10例后续接受肾移植、另15例目前在等待名单。全部移植肾功能正常,中位肌酐1.5(1.2–1.6)mg/dL。作者认为减重与移植团队协作可为肥胖ESRD患者提供移植路径,并可能减轻医疗差异。
要点
- 183例ESRD患者转诊减重团队,36例接受MBS(20例胃旁路术、16例袖状胃切除术)。
- 10例MBS后接受肾移植,另15例目前在移植等待名单。
- 全部移植肾功能正常,中位肌酐1.5(1.2–1.6)mg/dL(肾小球滤过率46[36.3–71])。
核心结论
- 减重与移植手术团队协作可为肥胖ESRD患者提供通往移植的路径,并可能减轻现有医疗差异。
- 接受MBS的ESRD患者有需注意的独特并发症。
- 合并症改善可能带来更优的移植后结局。
研究设计与样本
- 单中心研究,2019年1月至2023年6月移植团队转诊至减重团队的183例ESRD患者。
- 36例接受MBS(20例Roux-en-Y胃旁路术、16例袖状胃切除术),10例后续接受移植,另15例目前在等待名单。
- 两个手术团队共享营养师、社会工作者和共同数据库等资源,以便团队间顺畅过渡。
主要发现
- 全部转诊者平均起始BMI为46.4 kg/m²,移植时平均BMI为33.9 kg/m²。
- 降压药平均数量由术前2种(范围2–4)降至术后1种(范围1–3)。
- 血红蛋白A1C由术前平均6.2(范围5.4–7.6)改善至术后5.2(范围4.6–5.8)。
- 全部移植肾功能正常,中位肌酐1.5(1.2–1.6)mg/dL(肾小球滤过率46[36.3–71])。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An elevated BMI is a major cause of transplant preclusion for patients with end-stage renal disease (ESRD). This phenomenon exacerbates existing socioeconomic and racial disparities and increases the economic burden of maintaining patients on dialysis. Metabolic bariatric surgery (MBS) in such patients is not widely available. Our center created a collaborative program to undergo weight loss surgery before obtaining a kidney transplant. STUDY DESIGN: We studied the outcomes of these patients after MBS and transplant surgery. One hundred eighty-three patients with ESRD were referred to the bariatric team by the transplant team between January 2019 and June 2023. Of these, 36 patients underwent MBS (20 underwent Roux-en-Y gastric bypass and 16 underwent sleeve gastrectomy), and 10 underwent subsequent transplantation, with another 15 currently waitlisted. Both surgical teams shared resources, including dieticians, social workers, and a common database, for easy transition between teams. RESULTS: The mean starting BMI for all referrals was 46.4 kg/m 2 and was 33.9 kg/m 2 at the time of transplant. The average number of hypertension medications decreased from 2 (range 2 to 4) presurgery to 1 (range 1 to 3) postsurgery. Similarly, hemoglobin A1C levels improved, with preoperative averages at 6.2 (range 5.4 to 7.6) and postoperative levels at 5.2 (range 4.6 to 5.8) All transplants are currently functioning, with a median creatinine of 1.5 (1.2 to 1.6) mg/dL (glomerular filtration rate 46 [36.3 to 71]). CONCLUSIONS: A collaborative approach between bariatric and transplant surgery teams offers a pathway toward transplant for obese ESRD patients and potentially alleviates existing healthcare disparities. ESRD patients who undergo MBS have unique complications to be aware of. The improvement in comorbidities may lead to superior posttransplant outcomes.
引用
- Levy S, Attia A, Omar M, et al. Collaborative Approach Toward Transplant Candidacy for Obese Patients with End-Stage Renal Disease. J Am Coll Surg. 2024. PMID: 38470035. doi:10.1097/XCS.0000000000000962
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。